Unknown

Dataset Information

0

Cessation of Face Mask Use after COVID-19 Vaccination in Patients with Diabetes: Prevalence and Determinants.


ABSTRACT: Studies on the cessation of face mask use after a COVID-19 vaccine in patients with diabetes are not available, despite their greater predisposition to complications. We estimated the prevalence of cessation of face mask use after receiving the COVID-19 vaccine in patients with diabetes and identified which factor was most strongly associated with non-use. This was a cross-sectional study in patients with diabetes 18-70 years with at least one dose of vaccine against COVID-19 (n = 288). Participants were asked to respond face-to-face to a questionnaire in a primary care center. Descriptive statistics, chi-square tests, and multivariate binary logistic regression were used for analyzing the association between vulnerability, benefits, barriers, self-efficacy, vaccine expectations (independent variables), and cessation of use (dependent variable), controlling for sociodemographic, smoking, medical, vaccine, and COVID-19 history. The prevalence of cessation of face masks was 25.3% (95% CI 20.2, 30.5). Not feeling vulnerable to hospitalization increased the odds of non-use (adjusted OR = 3.3, 95% CI 1.2, 8.6), while perceiving benefits did the opposite (adjusted OR = 0.4, 95% CI 0.2, 0.9). The prevalence was low, and only two factors were associated with the cessation of face mask use after COVID-19 vaccination in patients with type 2 diabetes.

SUBMITTER: Cordero Franco HF 

PROVIDER: S-EPMC9956089 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cessation of Face Mask Use after COVID-19 Vaccination in Patients with Diabetes: Prevalence and Determinants.

Cordero Franco Hid Felizardo HF   Salinas Martínez Ana María AM   Martínez Martínez Diana Laura DL   Santiago Jarquin Blanca Reyna BR   Guzmán de la Garza Francisco Javier FJ  

International journal of environmental research and public health 20230204 4


Studies on the cessation of face mask use after a COVID-19 vaccine in patients with diabetes are not available, despite their greater predisposition to complications. We estimated the prevalence of cessation of face mask use after receiving the COVID-19 vaccine in patients with diabetes and identified which factor was most strongly associated with non-use. This was a cross-sectional study in patients with diabetes 18-70 years with at least one dose of vaccine against COVID-19 (<i>n</i> = 288). P  ...[more]

Similar Datasets

| S-EPMC8903840 | biostudies-literature
| S-EPMC10924563 | biostudies-literature
| S-EPMC9838719 | biostudies-literature
| S-EPMC8213701 | biostudies-literature
| S-EPMC7642487 | biostudies-literature
| S-EPMC7543707 | biostudies-literature
| S-EPMC8509869 | biostudies-literature
| S-EPMC11698284 | biostudies-literature
| S-EPMC7835129 | biostudies-literature
| S-EPMC7276053 | biostudies-literature